High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$744K
$744,772
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
KYMR
M
Kymera Therapeutics, Inc.
Albers Jeffrey W.
• Director
Equity Compensation
2025-12-08
$70,900x2
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
Director
Equity Compensation
|
2025-12-08 | $70,900x2 | M | Form 4 |
|
KYMR
S
Kymera Therapeutics, Inc.
Albers Jeffrey W.
• Director
10b5-1 SellΔOwn -55.0%
2025-12-08
$448,823x2
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
Director
10b5-1 SellΔOwn -55.0%
|
2025-12-08 | $448,823x2 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
Director
Other
|
2025-10-13 | $51,700 | M | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
Director
10b5-1 Sell
|
2025-10-13 | $295,949 | S | Form 4 |